Pfizer (PFE) Tops Q3 EPS by 14c, Beats on Revenue; Offers FY26 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Wall St futures mixed as Apple falls on margin warning, midterm results awaited
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- Goldman data shows hedge funds cut leverage at fastest pace since March
| Pfizer Inc. (NYSE: PFE) | Delayed: 30.67 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.67 | 52 Week High | $37.39 | |||
| Open | $30.67 | 52 Week Low | $28.25 | |||
| Day High | $30.67 | P/E | 18.59 | |||
| Day Low | $30.67 | EPS | $1.65 | |||
| Volume | 1,187,295 | |||||
